Systems Director of Anticoagulation Services, Beth Israel Lahey Health. NATF Medical Advisory Board & AC Forum ACE committee. Mom of 3 🧘🏻♀️Tweets are my own
The biggest take-home points from our paper should be:
💊Medication reconciliation is vital
💡Know your resources for managing interactions
👩🏻⚕️ Find a pharmacist to help
✅ Stay up to date. Recs may change as more data is collected
@JACCJournals@SarjuGanatraMD@sonuabrahammd
A dedicated commentary opines on the #pharmacotherapy 💊 recs in the #PE guideline. “…Mounting evidence suggests that apixaban may provide a more favorable safety profile than rivaroxaban.” 👇
https://t.co/tK4qBo74JS
Do your patients have questions about #bloodclots, #anticoagulation, or managing a new #VTE diagnosis?
Invite them to join our Blood Clot Support Group tomorrow (Thurs 9/18) at 7 PM ET | 6 PM CT with @AnticoagPharmD!
💜 RSVP here: https://t.co/OonStZPG80 💜
Artificial sweeteners are everywhere, but what do we really know about their impact on clotting, heart health, & metabolism?
This @Vasculearn Network article breaks down the science in plain language. Great to share with patients!
🔗https://t.co/pVrfWCL88R
#PatientEducation#VTE
🎧 New #Curbsiders episode!
💊 #490: Anticoagulation for VTE w/ Dr. Tara Lech, PharmD
@AnticoagPharmD
✅ Choosing the right DOAC
🤰 Special pops: pregnancy, low BMI
✈️ Air travel prophylaxis
🚨 Treatment failure & reversal agents
🔗 https://t.co/WAA2nXaTKO
🪩✨Catch up on the latest science & curated updates from #ISTH2025 without all of the noise at @Vasculearn
https://t.co/BPjR8wz6Dc (login or signup to access)
Join the community to access posts and commentary from myself, @AJTafur & @johnfanikos#TwitteRx#MedTwitter
💥If you enjoyed seeing our live updates from #ISTH2025, you can 👀 the major highlights in the VLN newsletter or log into the @Vasculearn#ISTH2025 Community Page https://t.co/BPjR8wyyNE to see ALL the posts & interact with the community. I look forward to seeing you there!
🚨 Missed ISTH 2025? We’ve got you.
Our Board handpicked the 8 biggest highlights you need to know! From the COBRRA trial comparing rivaroxaban vs. apixaban, to new real-world data shaping PE treatment timelines and more.
Think:
🧠 Real insights
💉 Real-world relevance
⏱️ Faster decisions, better outcomes
Catch the full recap from Vasculearn Network now: https://t.co/NaYEu7BbJb
Thanks to our awesome boots on the ground leaders @AJTafur and @AnticoagPharmD
🎙️ New Episode Alert: “Clot, Clot, Who’s There?”
Anticoagulation therapy is life-saving—but also life-changing. In today’s episode, Dr. Bethany Samuelson Bannow @bsamuelson_md is joined by Dr. Erik Klok @Erik_Klok_MD and Dr. Geoff Barnes @GBarnesMD to talk about how we talk about anticoagulation. 🗣️💊
They’ll cover:
✅ Common patient concerns
✅ How to improve medication adherence
✅ Lifestyle conversations that matter
✅ Using shared decision-making to build trust
Whether you’re a clinician or someone supporting patients on this journey, this one’s a must-listen.
🎧 Brought to you by @isth International Society on Thrombosis and Haemostasis (ISTH) in partnership with Vasculearn Network and the editors of Thrombosis and Haemostasis at Thieme @ThiemeIntl
#VascularHealth #Anticoagulation #ClotClotWhosThere #Vasculearn #ISTH #SharedDecisionMaking #MedicalPodcast
https://t.co/UE73PujinI
Treatment of VTE does NOT end at discharge!
💡We need a clinical framework in place to follow pts and allow for early detection of post VTE symptoms and patient reported concerns that impact Quality of Life
#ISTH2025#VTE#AnticoagStewrship
@Vasculearn has been working hard to meet this need. Check out their VTE toolkit to help you communicate with your patient over the course of their treatment
https://t.co/STjiQG4c8k
Excited to be at #ISTH2025
I am attending the sessions keeping @Vasculearn Network up to date with the latest in coagulation management.
Let me know if there are any sessions you want to see and follow along on our community page https://t.co/l1s748mLEb
Great session on the use of preemptive AC for suspected PE. An international survey of ED MDs showed
- Low use of preemptive AC
- ⬆️ concern for cardiorespiratory ⬇️ vs 🩸🩸
- ⬇️ unawares of guidelines/protocols
❓What is the role for pharmacists #ACstewardship#ISTH2025
💬 Hi everyone! Just a quick reminder that our Women's Support Group meets tonight at 7:00 PM Eastern on Zoom with host @AnticoagPharmD !
💜 This is a safe, supportive space for women navigating blood clots, hormonal changes, pregnancy-related concerns, and other health journeys. Whether you’ve attended before or are brand new—you're very welcome here.
🔗 We’ll be meeting in a live video room right in our new community:
https://t.co/EZ9o59ITHd
💻 Need a refresher on how to join a live event? Check out our quick walkthrough:
https://t.co/YdeiMPkgSl
✅ You can join the room 5 minutes before start time
✅ Share your questions prior to the event in the comments space:
✅ Be sure to use Chrome or Firefox for the best experience
✅ The chat is public—please avoid sharing sensitive personal info
We hope to see you there!
💜@Vasculearn Network is hosting a Women's Health Support Group May 12th @ 7PM EST💜
This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis
👉Register https://t.co/aaHX7WRZK2
💜@Vasculearn Network is hosting a Women's Health Support Group May 12th @ 7PM EST💜
This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis
👉Register https://t.co/Q3J0VAmJcu
Do you treat women with blood clots?
Please refer them to @Vasculearn Network's Women's Support Group on May 12th @ 7PM EST
I will be there to answer questions, share educational resources & support them as they learn to VascuLive with their diagnosis
https://t.co/GzWXT9B7DM